William Blair analyst Andy Hsieh initiates coverage on Skye Bioscience (NASDAQ: SKYE) with a Outperform rating.The analyst comments: "Skye is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE